Clinical Trial Update: A Retrospective Cohort Study of Infusion Reactions Due to Vectibix

View source ↗

Summary

A retrospective cohort study analyzes infusion reactions associated with Vectibix (panitumumab). It adds real-world safety data on the use of this EGFR-targetin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Vectibix (panitumumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Infusion Reaction | Status: COMPLETED